Kadir A - Search Results

1

Positron emission tomography imaging and clinical progression in relation to molecular pathology in the first Pittsburgh Compound B positron emission tomography patient with Alzheimer's disease.

Kadir A, Marutle A, Gonzalez D, Schöll M, Almkvist O, Mousavi M, Mustafiz T, Darreh-Shori T, Nennesmo I, Nordberg A. Kadir A, et al. Brain. 2011 Jan;134(Pt 1):301-17. doi: 10.1093/brain/awq349. Epub 2010 Dec 13. Brain. 2011. PMID: 21149866 Free PMC article.

2

Differential CSF butyrylcholinesterase levels in Alzheimer's disease patients with the ApoE epsilon4 allele, in relation to cognitive function and cerebral glucose metabolism.

Darreh-Shori T, Brimijoin S, Kadir A, Almkvist O, Nordberg A. Darreh-Shori T, et al. Among authors: kadir a. Neurobiol Dis. 2006 Nov;24(2):326-33. doi: 10.1016/j.nbd.2006.07.013. Epub 2006 Sep 14. Neurobiol Dis. 2006. PMID: 16973370

3

PET imaging of cortical 11C-nicotine binding correlates with the cognitive function of attention in Alzheimer's disease.

Kadir A, Almkvist O, Wall A, Långström B, Nordberg A. Kadir A, et al. Psychopharmacology (Berl). 2006 Nov;188(4):509-20. doi: 10.1007/s00213-006-0447-7. Epub 2006 Jul 11. Psychopharmacology (Berl). 2006. PMID: 16832659 Clinical Trial.

4

Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.

Kadir A, Darreh-Shori T, Almkvist O, Wall A, Långström B, Nordberg A. Kadir A, et al. Psychopharmacology (Berl). 2007 May;191(4):1005-14. doi: 10.1007/s00213-007-0725-z. Epub 2007 Feb 20. Psychopharmacology (Berl). 2007. PMID: 17310387 Clinical Trial.

5

Effect of phenserine treatment on brain functional activity and amyloid in Alzheimer's disease.

Kadir A, Andreasen N, Almkvist O, Wall A, Forsberg A, Engler H, Hagman G, Lärksäter M, Winblad B, Zetterberg H, Blennow K, Långström B, Nordberg A. Kadir A, et al. Ann Neurol. 2008 May;63(5):621-31. doi: 10.1002/ana.21345. Ann Neurol. 2008. PMID: 18300284 Clinical Trial.

6

The use of PET in Alzheimer disease.

Nordberg A, Rinne JO, Kadir A, Långström B. Nordberg A, et al. Among authors: kadir a. Nat Rev Neurol. 2010 Feb;6(2):78-87. doi: 10.1038/nrneurol.2009.217. Nat Rev Neurol. 2010. PMID: 20139997 Review.

7

Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease.

Kadir A, Almkvist O, Forsberg A, Wall A, Engler H, Långström B, Nordberg A. Kadir A, et al. Neurobiol Aging. 2012 Jan;33(1):198.e1-14. doi: 10.1016/j.neurobiolaging.2010.06.015. Epub 2010 Aug 4. Neurobiol Aging. 2012. PMID: 20688420

8

Target-specific PET probes for neurodegenerative disorders related to dementia.

Kadir A, Nordberg A. Kadir A, et al. J Nucl Med. 2010 Sep;51(9):1418-30. doi: 10.2967/jnumed.110.077164. J Nucl Med. 2010. PMID: 20810758 Free article. Review.

9

Degree of abnormality is associated with rate of change in measures of beta-amyloid, glucose metabolism and cognition in an autopsy-verified Alzheimer's disease case.

Almkvist O, Kadir A, Nordberg A. Almkvist O, et al. Among authors: kadir a. Neurocase. 2015;21(6):738-47. doi: 10.1080/13554794.2014.979835. Epub 2014 Dec 12. Neurocase. 2015. PMID: 25494540

10

Inhibition of acetylcholinesterase in CSF versus brain assessed by 11C-PMP PET in AD patients treated with galantamine.

Darreh-Shori T, Kadir A, Almkvist O, Grut M, Wall A, Blomquist G, Eriksson B, Långström B, Nordberg A. Darreh-Shori T, et al. Among authors: kadir a. Neurobiol Aging. 2008 Feb;29(2):168-84. doi: 10.1016/j.neurobiolaging.2006.09.020. Epub 2006 Dec 29. Neurobiol Aging. 2008. PMID: 17196712 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters